Is Abbott Laboratories halal to invest in?

According to Musaffa's Shariah screening methodology, Abbott Laboratories (ABT) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Abbott Laboratories a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Abbott Laboratories using these criteria to determine its compliance status.

Can Muslims buy shares of Abbott Laboratories?

Muslim investors may consider investing in Abbott Laboratories if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Abbott Laboratories classified as HALAL?

Musaffa determines the Shariah status of Abbott Laboratories by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Abbott Laboratories updated?

The Shariah compliance status of Abbott Laboratories may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Abbott Laboratories become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Abbott Laboratories?

You can check the latest Shariah compliance status of Abbott Laboratories on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ABT Shariah Compliance

Screening Methodology: AAOIFI

UNLOCK FOR FREE

Last Updated: February 23, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Abbott Laboratories (ABT)

Based on 35 analysts giving stock ratings to Abbott Laboratories in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Abbott Laboratories. Stock Analysis ABT

United States Health Care Large Cap Report: 2025 Annual

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.

Key Statistics of Abbott Laboratories (ABT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$101.31$103.84

Today's Open

$103.13

Volume

8.29M

P/E Ratio (TTM)

27.59

52 Week Range

$100.88$139.06

Market Cap

190.06B

Avg. Volume

12.65M

Dividend Yield

2.29%

Financial Metrics & Statements of Abbott Laboratories (ABT)

FAQ's for Abbott Laboratories (ABT)

According to Musaffa’s Shariah screening methodology, Abbott Laboratories (ABT) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.